Monitor ADS trading post-ratio change to confirm the stock price stays above $1.00 for 10 consecutive business days by October 26, 2026. Failure to regain compliance could lead to delisting risk.
Price Chart
Executive Summary
Immutep is changing its ADS ratio from 1 ADS = 10 ordinary shares to 1 ADS = 200 ordinary shares, effective September 28, 2026, to address Nasdaq's minimum bid price deficiency. The change has the same effect as a 1-for-20 reverse ADS split and is a technical step to regain compliance with the $1.00 minimum bid price requirement by the October 26, 2026 deadline. No financial or operational impact on the company.
Key Facts
- ADS ratio changes from 1 ADS = 10 ordinary shares to 1 ADS = 200 ordinary shares effective September 28, 2026.
- Effective as a 1-for-20 reverse ADS split; approximately 32.8 million ADSs before change, ~1.64 million after.
- Ordinary shares on issue unchanged at 1,473,721,306; no change to capital structure, cash position, or clinical programs.
- Nasdaq notified Immutep on April 30, 2026 of bid price below $1.00 for 30 consecutive business days; compliance deadline is October 26, 2026.
- Ratio set to provide generous margin above $1.00 to avoid a new compliance period if deficiency recurs within 12 months.
Financial Impact
No financial impact; ADS ratio change does not affect capital structure, cash, or clinical programs.
Risk Factors
- If ADS price does not sustain above $1.00 for 10 consecutive business days by October 26, 2026, Nasdaq may delist the ADSs.
- Fractional ADS holders will receive cash in lieu, which may create small selling pressure.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-397189 |
| Document: d79097d6k.htm | 0001193125-26-397189 |
| Document: 0001193125-26-397189-index-headers.html | 0001193125-26-397189 |
| Document: 0001193125-26-397189-index.html | 0001193125-26-397189 |
| Document: 0001193125-26-397189.txt | 0001193125-26-397189 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 20-F | $3.20 $3.10 | ▲ +3.13% | ▲ +3.84% | $3.17 (+0.94%) |
Oct 13, 2026 13d ago | 6-K | $3.38 $3.21 | ▼ −5.03% | ▼ −5.31% | $3.17 (−6.21%) |
Sep 22, 2026 5w ago | 6-K | $0.2800 $0.2700 | ▼ −3.57% | ▼ −2.85% | $3.17 (+1032.14%) |
Sep 1, 2026 7w ago | 6-K | $0.3800 $0.3700 | ▲ +2.63% | ▲ +3.68% | $3.17 (−734.21%) |
Jul 13, 2026 15w ago | 6-K | $0.4328 $0.4367 | ▲ +0.90% | ▲ +0.50% | $3.17 (+632.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers